Skip to main content
. 2019 Feb 27;3(4):290–294. doi: 10.1002/jgh3.12152

Table 1.

Comparison of baseline characteristics and outcome between in patients with AKI stages 1A and 1B, categorized according to level of serum creatinine at admission

Sl No Parameters AKI 1A (n = 100) AKI 1B (n = 82) P value
1 Age (mean ± SD) 50.05 ± 11.96 51.04 ± 13.09 0.593
2 Gender (male) (male, [%]) 92 (92) 75 (91.5) 0.896
3 BMI (kg/m2) (mean ± SD) 22.04 ± 3.76 22.29 ± 4.11 0.670
4 MAP (mmHg) (mean ± SD) 86.37 ± 9.69 83.63 ± 11.55 0.084
5 Etiology of cirrhosis (alcohol [%]) 63 (63) 52 (63.4) 0.877
6 Total leucocyte count (103 cells/dL) (median [IQR]) 8200 (6425–10 350) 9400 (7400–12 600) 0.048
7 Serum bilirubin (total) (mg/dL) (median [IQR]) 8.60 (5.79–13.95) 10.60 (6.90–22.40) 0.001
8 Serum creatinine (mg/dL) (mean ± SD) 1.26 ± 0.09 1.70 ± 0.15 <0.001
9 Urea (mg/dL) (median [IQR]) 32.50 (25–42.75) 46.50 (37–63.50) <0.001
10 Serum protein (g/dL) (median [IQR]) 6.30 (5.83–7.08) 6.40 (5.78–7.30) 0.279
11 Serum albumin (g/dL) (mean ± SD) 2.77 ± 0.51 2.61 ± 0.52 0.035
12 Serum sodium (mEq/L) (mean ± SD) 135.34 ± 7.27 131.77 ± 16.11 0.066
13 Serum potassium (mEq/L) (median [IQR]) 4.20 (3.90–4.70) 4.20 (3.50–4.90) 0.324
14 SAAG (mean ± SD) 2.31 ± 0.56 2.19 ± 0.56 0.149
15 INR (mean ± SD) 1.79 ± 0.49 1.96 ± 0.81 0.101
16 MELD (UNOS) (mean ± SD) 18.51 ± 5.25 23.95 ± 7.22 <0.001
17 MELD (Na+) (mean ± SD) 21.07 ± 5.83 26.56 ± 7.14 <0.001
18 CTP score (mean ± SD) 10.55 ± 2.37 11.55 ± 2.25 0.004
19 CTP (%) A 3 (3) 2 (2.4) 0.342
B 26 (26) 15 (18.3)
C 71 (71) 65 (79.3)
20 Variceal bleeding (%) 58 (58) 33 (40.2) 0.017
21 Infection (%) 39 (39) 47 (57.3) 0.014
22 Ascites (%) 94 (94) 79 (96.3) 0.469
23 Encephalopathy (%) 84 (84) 65 (79.3) 0.410

AKI, acute kidney injury; BMI, body mass index; CTP, Child‐Turcotte‐Pugh; INR, International Normalized Ratio; IQR, interquartile range; MAP, mean arterial pressure; MELD, model for end‐stage liver disease; SAAG, serum‐ascites albumin gradient; SD, standard deviation; UNOS, The United Network for Organ Sharing.